AI assistant
NORTHROP GRUMMAN CORP /DE/ — Director's Dealing 2017
Feb 22, 2017
29899_dirs_2017-02-22_405b6166-9023-4b69-a677-9a7d2f4f02c8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NORTHROP GRUMMAN CORP /DE/ (NOC)
CIK: 0001133421
Period of Report: 2017-02-17
Reporting Person: DAVIS LISA R (Corp VP, Communications)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-02-17 | Common Stock | M | 1865.0700 | $0.0000 | Acquired | 1865.0700 | Direct |
| 2017-02-17 | Common Stock | F | 682.0000 | $243.5800 | Disposed | 1183.0700 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-02-17 | Restricted Performance Stock Rights | $ | A | 3696.0700 | Acquired | Common Stock (3696.0700) | Direct | |
| 2017-02-17 | Restricted Performance Stock Rights | $ | M | 1865.0700 | Disposed | Common Stock (1865.0700) | Direct | |
| 2017-02-17 | Restricted Stock Rights | $ | A | 1276.0000 | Acquired | Common Stock (1276.0000) | Direct |
Footnotes
F1: Shares issued in settlement of Restricted Performance Stock Rights ("RPSRs") granted under the 2011 Long-Term Incentive Stock Plan ("LTISP") on 2/19/14 with a valuation of performance measurement period ("measurement period") ended 12/31/16. The RPSRs were settled at 153% of target.
F2: Shares surrendered to issuer in payment of tax liability in connection with settlement of RPSRs in accordance with Rule 16b-3(e)
F3: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the application performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d).
F4: The RPSRs acquired include (i) 646.07 vested RPSRs with respect to the measurement period ended 12/31/16 acquired due to settlement of the 2014 RPSRs held at 153% of the target award and (ii) 3,050 unvested RPSRs granted under the LTISP on 2/17/17 with a measurement period ending on 12/31/19.
F5: Total amount includes 1,865.07 vested RPSRs granted under the LTISP on 7/29/14 with a measurement period ended on 12/31/16; 3,050 RPSRs granted on 2/17/17 with a measurement period ending on 12/31/19; 3,631 RPSRs granted on 2/17/16 with a measurement period ending on 12/31/18; and 955 RPSRs granted on 2/18/15 with a measurement period ending on 12/31/17.
F6: Total amount includes 3,050 RPSRs granted on 2/17/17 with a measurement period ending on 12/31/19; 3,631 RPSRs granted on 2/17/16 with a measurement period ending on 12/31/18; and 955 RPSRs granted on 2/18/15 with a measurement period ending on 12/31/17.
F7: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. The RSRs were granted under the LTISP on 2/17/17 and will vest on 2/17/20.
F8: Total amount includes 1,276 RSRs granted under the LTISP on 2/17/17 that will vest on 2/17/20; 1,648 RSRs granted under the LTISP on 2/17/16 that will vest on 2/17/19; 409 RSRs granted under the LTISP on 2/18/15 that will vest on 2/18/18; and 1,315 RSRs granted under the LTISP on 7/29/14 that vested on 7/29/17.